QuickLinks -- Click here to rapidly navigate through this document

~~UNITED STATES~~ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

September 9, 2002 Date of Report (Date of ~~Earliest~~earliest ~~Event~~event ~~Reported~~reported): ~~May 22, 2002~~

~~Ostex~~OSTEX ~~International~~INTERNATIONAL, ~~Inc~~ INC. (Exact name of registrant as specified in its charter)

Washington (State or other jurisdiction of incorporation or organization)	0-25250 (Commission File Number)	91-1450247 (I.R.S. Employer Identification No.)
Washington	0-25250	91-1450247
2203 Airport Way South, Suite 400 Seattle, WA (Address of principal executive offices)		98134 (Zip Code)
(State or other jurisdiction of incorporation)	(Commission File No.)	(IRS Employer Identification No.)

~~206/292-8082~~2203 Airport Way South, Suite 400, Seattle, Washington 98134 (~~Registrant's~~Address ~~telephone~~of ~~number~~principal executive offices, including ~~area~~zip code)

~~Item~~(206) ~~4. Changes in~~ 292-8082 (Registrant's ~~Certifying~~telephone ~~Accountant.~~ number, including area code)

~~Previous Independent~~Item ~~Accountant~~5. Other Events

On ~~May~~ September 229, 2002, Ostex International, Inc., a Washington corporation ("Ostex"), ~~decided~~announced tothat ~~dismiss~~it ~~Arthur~~has ~~Andersen~~entered ~~LLP~~into an Agreement and Plan of Merger (the "~~Arthur~~Merger ~~Andersen~~Agreement") asby ~~our~~and ~~independent~~among ~~accountant~~Inverness Medical Innovations, Inc., ~~The~~a ~~decision~~Delaware corporation ("Inverness"), Ostex and Geras Acquisition Corp., a Washington subsidiary and a wholly-owned subsidiary of Inverness ("Merger Subsidiary"). Pursuant to ~~dismiss~~the ~~Arthur~~Merger ~~Andersen~~Agreement ~~was~~and subject to the terms and conditions set forth therein, Merger Subsidiary will be merged with and into ~~recommended~~Ostex, bywith Ostex being the ~~Audit~~surviving ~~Committee~~corporation of the merger (the "Merger"), and as a result of the Merger, Ostex ~~Board~~will become a wholly owned subsidiary of ~~Directors~~Inverness. The aggregate number of shares of Inverness common stock to be issued in the Merger in exchange for Ostex' outstanding shares and ~~approved~~to bybe reserved for the options and warrants to be assumed by Inverness is 2.3 million shares, with each share of Ostex ~~Board~~common stock expected to convert into approximately 0.1494 shares of ~~Directors~~Inverness common stock. Based on Ostex' current capital structure, approximately 1.88 million shares of Inverness common stock are to be issued at closing and approximately 420,000 shares are to be reserved for assumed options and warrants.

~~During~~ Certain shareholders of Ostex' ~~two~~who ~~most~~hold ~~recent~~an ~~fiscal~~aggregate ~~years~~of ~~and~~approximately ~~through~~19.8% of the ~~date~~outstanding ofOstex ~~this~~common ~~Form 8-K,~~stock ~~there~~have ~~were~~entered nointo ~~disagreements~~a voting agreement (the "Voting Agreement") with Inverness ~~Arthur~~which ~~Andersen~~provides onthat ~~any~~they ~~matter~~will vote their shares in favor of ~~accounting~~the ~~principles~~Merger. ~~or practices~~Additionally, ~~financial~~in ~~statement~~connection ~~disclosure,~~with orthe ~~auditing~~execution ~~scope~~of orthe ~~procedure~~Merger ~~which~~Agreement, ifInverness ~~not~~and ~~resolved~~Ostex toentered ~~Arthur~~into ~~Andersen's~~a ~~satisfaction~~Stock Option Agreement (the "Option Agreement"), ~~would~~pursuant ~~have~~to ~~caused~~which ~~Arthur~~Ostex ~~Andersen~~granted Inverness an option to ~~make~~purchase, ~~reference~~in the circumstances specified in the Option Agreement, up to 19.9% of the ~~subject~~outstanding ~~matter~~shares inof Ostex common stock. In connection with ~~its~~the ~~report~~execution onof the ~~Plans'~~Merger ~~financial~~Agreement, ~~statements~~Ostex also entered into an agreement (the "Loan Agreement"), pursuant to which Inverness will make, or arrange for ~~such~~one ~~years;~~of ~~and~~its ~~there~~affiliates ~~were~~to nomake, ~~reportable~~loans ~~events~~to asOstex, ~~defined~~up into ~~Item~~an ~~304(a)(1)(v)~~ aggregate amount of ~~Regulation~~$2 ~~S-K~~million, on the terms and conditions and in the circumstances specified in the Loan Agreement.

~~Ostex~~ A ~~has~~copy ~~provided~~of ~~Arthur~~the ~~Andersen~~joint ~~with~~press release announcing execution of the Merger Agreement and related agreements was issued September 9, 2002 and is attached hereto as Exhibit 99.1. A copy of the Merger Agreement is attached hereto as Exhibit 2.1, a copy of the ~~foregoing~~Voting ~~disclosures~~Agreement ~~and~~is ~~has~~attached ~~requested~~hereto as Exhibit 2.2, a ~~letter~~copy ~~from~~of ~~Arthur~~the ~~Andersen~~Option ~~stating~~Agreement ~~whether~~is itattached ~~agrees~~hereto ~~with~~as Exhibit 2.3, and a copy of the ~~disclosures~~Loan ~~contained~~Agreement ~~herein~~is attached hereto as Exhibit 2.4. ~~Ostex~~The ~~will file~~foregoing ~~such~~description ~~letter~~is byqualified anin ~~amendment~~its entirety by reference to ~~this~~the ~~Form 8-K~~full text of such exhibits, and each such exhibit is incorporated herein by reference.

~~New Independent~~ ~~Accountant~~Item 7. Financial Statements, Pro Forma Financial Information and Exhibits

(c): Exhibits

On May 22, 2002, Ostex engaged KPMG LLP ("KPMG") as the firm of independent auditors to audit Ostex' financial statements for the fiscal year ending December 31, 2002. The decision to engage KPMG was recommended by the Ostex Audit Committee and approved by the Ostex Board of Directors. Since January 2000, we have not consulted KPMG regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, that was an important factor we considered in reaching a decision on an accounting, auditing, or financial reporting issue, or the type of audit opinion that might be rendered on our financial statements, or (ii) any matter that was the subject of either a disagreement or reportable event.

Number		Description
2.1		Agreement and Plan of Merger dated as of September 6, 2002, by and among Inverness Medical Innovations, Inc., Geras Acquisition Corp. and Ostex International, Inc.
2.2		Voting Agreement dated as of September 6, 2002, by and among Inverness Medical Innovations, Inc., Ostex International, Inc. and certain Ostex shareholders
2.3		Stock Option Agreement dated as of September 6, 2002, by and between Ostex International, Inc. and Inverness Medical Innovations, Inc.
2.4		Loan Agreement dated as of September 6, 2002, by and between Ostex International, Inc. and Inverness Medical Innovations, Inc.
99.1		Joint Press Release issued by Inverness Medical Innovations, Inc. and Ostex International, Inc. on September 9, 2002

~~Item 7. Financial Statements and Exhibits~~ 2

~~Exhibit~~ 16 ~~Letter from Arthur Andersen LLP to the Securities and Exchange Commission dated May x, 2002~~ SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned ~~SIGNATURE~~ hereunto duly authorized.

~~Pursuant to the requirements of the Securities Exchange Act of 1934~~Date: September 9, ~~the~~2002 ~~registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~

		OSTEX INTERNATIONAL, INC.
Date: May 30, 2002		By		/s/ THOMAS BOLOGNA Thomas Bologna Chairman, CEO and President

OSTEX INTERNATIONAL, INC.
By:	/s/ THOMAS A. BOLOGNA
	Name:	Thomas A. Bologna
	Title:	President and Chief Executive Officer

EXHIBIT INDEX

Number		Description		Page Number
Exhibit No.		Description
16*		Letter from Arthur Andersen LLP regarding change in certifying accountant
2.1		Agreement and Plan of Merger dated as of September 6, 2002, by and among Inverness Medical Innovations, Inc., Geras Acquisition Corp. and Ostex International, Inc.
2.2		Voting Agreement dated as of September 6, 2002, by and among Inverness Medical Innovations, Inc., Ostex International, Inc. and certain Ostex shareholders
2.3		Stock Option Agreement dated as of September 6, 2002, by and between Ostex International, Inc. and Inverness Medical Innovations, Inc.
2.4		Loan Agreement dated as of September 6, 2002, by and between Ostex International, Inc. and Inverness Medical Innovations, Inc.
99.1		Joint Press Release issued by Inverness Medical Innovations, Inc. and Ostex International, Inc. on September 9, 2002

QuickLinks

SIGNATURES
EXHIBIT INDEX

Filing Compare · OSTEX INTERNATIONAL INC /WA/